AAAAAA

   
Results: 1-14 |
Results: 14
Biosynthesis and processing of cathepsin K in cultured human osteoclasts
Authors: Rieman, DJ McClung, HA Dodds, RA Hwang, SM Lark, MW Holmes, S James, IE Drake, FH Gowen, M
Citation: Dj. Rieman et al., Biosynthesis and processing of cathepsin K in cultured human osteoclasts, BONE, 28(3), 2001, pp. 282-289
Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat
Authors: Lark, MW Stroup, GB Dodds, RA Kapadia, R Hoffman, SJ Hwang, SM James, IE Lechowska, B Liang, XG Rieman, DJ Salyers, KL Ward, K Smith, BR Miller, WH Huffman, WF Gowen, M
Citation: Mw. Lark et al., Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat, J BONE MIN, 16(2), 2001, pp. 319-327
Linking osteopetrosis end pycnodysostosis: Regulation of cathepsin K expression by the microphthalmia transcription factor family
Authors: Motyckova, G Weilbaecher, KN Horstmann, M Rieman, DJ Fisher, DZ Fisher, DE
Citation: G. Motyckova et al., Linking osteopetrosis end pycnodysostosis: Regulation of cathepsin K expression by the microphthalmia transcription factor family, P NAS US, 98(10), 2001, pp. 5798-5803
IL-1-and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase
Authors: Kumar, S Votta, BJ Rieman, DJ Badger, AM Gowen, M Lee, JC
Citation: S. Kumar et al., IL-1-and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase, J CELL PHYS, 187(3), 2001, pp. 294-303
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung
Authors: Underwood, DC Osborn, RR Bochnowicz, S Webb, EF Rieman, DJ Lee, JC Romanic, AM Adams, JL Hay, DWP Griswold, DE
Citation: Dc. Underwood et al., SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung, AM J P-LUNG, 279(5), 2000, pp. L895-L902
Identification and cloning of a human urea transporter HUT11, which is downregulated during adipogenesis of explant cultures of human bone
Authors: Prichett, WP Patton, AJ Field, JA Brun, KA Emery, JG Tan, KB Rieman, DJ McClung, HA Nadeau, DP Mooney, JL Suva, LJ Gowen, M Nuttall, ME
Citation: Wp. Prichett et al., Identification and cloning of a human urea transporter HUT11, which is downregulated during adipogenesis of explant cultures of human bone, J CELL BIOC, 76(4), 2000, pp. 639-650
Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic
Authors: Miller, WH Alberts, DP Bhatnagar, PK Bondinell, WE Callahan, JF Calvo, RR Cousins, RD Erhard, KF Heerding, DA Keenan, RM Kwon, C Manley, PJ Newlander, KA Ross, ST Samanen, JM Uzinskas, IN Venslavsky, JW Yuan, CCK Haltiwanger, RC Gowen, M Hwang, SM James, IE Lark, MW Rieman, DJ Stroup, GB Azzarano, LM Salyers, KL Smith, BR Ward, KW Johanson, KO Huffman, WF
Citation: Wh. Miller et al., Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic, J MED CHEM, 43(1), 2000, pp. 22-26
Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis
Authors: Badger, AM Griswold, DE Kapadia, R Blake, S Swift, BA Hoffman, SJ Stroup, GB Webb, E Rieman, DJ Gowen, M Boehm, JC Adams, JL Lee, JC
Citation: Am. Badger et al., Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis, ARTH RHEUM, 43(1), 2000, pp. 175-183
Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model
Authors: Miller, WH Bondinell, WE Cousins, RD Erhard, KF Jakas, DR Keenan, RM Ku, TW Newlander, KA Ross, ST Haltiwanger, RC Bradbeer, J Drake, FH Gowen, M Hoffman, SJ Hwang, SM James, IE Lark, MW Lechowska, B Rieman, DJ Stroup, GB Vasko-Moser, JA Zembryki, DL Azzarano, LM Adams, PC Salyers, KL Smith, BR Ward, KW Johanson, KO Huffman, WF
Citation: Wh. Miller et al., Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model, BIOORG MED, 9(13), 1999, pp. 1807-1812
Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis
Authors: Badger, AM Blake, SM Dodds, RA Griswold, DE Swift, BA Rieman, DJ Stroup, GB Hoffman, SJ Gowen, M
Citation: Am. Badger et al., Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis, J PHARM EXP, 291(3), 1999, pp. 1380-1386
Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis
Authors: Lark, MW Stroup, GB Hwang, SM James, IE Rieman, DJ Drake, FH Bradbeer, JN Mathur, A Erhard, KF Newlander, KA Ross, ST Salyers, KL Smith, BR Miller, WH Huffman, WF Gowen, M
Citation: Mw. Lark et al., Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis, J PHARM EXP, 291(2), 1999, pp. 612-617
Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions
Authors: Kumar, S Hand, AT Connor, JR Dodds, RA Ryan, PJ Trill, JJ Fisher, SM Nuttall, ME Lipshutz, DB Zou, C Hwang, SM Votta, BJ James, IE Rieman, DJ Gowen, M Lee, JC
Citation: S. Kumar et al., Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions, J BIOL CHEM, 274(24), 1999, pp. 17123-17131
Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonists
Authors: Keenan, RM Miller, WH Lago, MA Ali, FE Bondinell, WE Callahan, JF Calvo, RR Cousins, RD Hwang, SM Jakas, DR Ku, TW Kwon, C Nguyen, TT Reader, VA Rieman, DJ Ross, ST Takata, DT Uzinskas, IN Yuan, CCK Smith, BR
Citation: Rm. Keenan et al., Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonists, BIOORG MED, 8(22), 1998, pp. 3165-3170
Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis model
Authors: Keenan, RM Lago, MA Miller, WH Ali, FE Cousins, RD Hall, LB Hwang, SM Jakas, DR Kwon, C Louden, C Nguyen, TT Ohlstein, EH Rieman, DJ Ross, ST Samanen, JM Smith, BR Stadel, J Takata, DT Vickery, L Yuan, CCK Yue, TL
Citation: Rm. Keenan et al., Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis model, BIOORG MED, 8(22), 1998, pp. 3171-3176
Risultati: 1-14 |